SPL 0.00% 9.9¢ starpharma holdings limited

Nintedanib - Nintedanib/Docetaxel - Nintedanib/DepDocetaxel, page-5

  1. 12,897 Posts.
    lightbulb Created with Sketch. 1439
    Adenocarcinoma is a major lung cancer

    Starpharma's dep docetaxel in conjunction with nintedanib - I understand is focusing in clinical trials on this indication

    Last edited by antibotter: 06/09/17
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.